Picotamide is a platelet aggregation inhibitor.

It works as a thromboxane synthase inhibitor and a thromboxane receptor inhibitor, the latter by modifying cellular responses to activation of the thromboxane receptor.

[1] Picotamide is licensed in Italy for the treatment of clinical arterial thrombosis and peripheral artery disease.

[2] This drug article relating to the blood and blood forming organs is a stub.

You can help Wikipedia by expanding it.